Navigation Links
Leading Healthcare Organizations Share Successes Realized with MEDai's Predictive Analytics
Date:3/16/2009

- MEDai Clients Present at the 6th Annual New Innovations & Applications

in Predictive Modeling Conference -

ORLANDO, Fla., March 16 /PRNewswire/ -- MEDai, Inc., headquartered in Orlando, FL, and a leading provider of advanced solutions for healthcare that utilize award-winning predictive analytics, announced today that several of its clients will be presenting the benefits and successes they have realized from utilizing MEDai's suite of predictive analytic solutions. The presentations, taking place during World Research Group's 6th Annual New Innovations & Applications in Predictive Modeling Conference in Las Vegas, NV, March 25-26, 2009, will provide insight on how payors can maximize and improve resource allocation, improve the impact of care management efforts, and more effectively engage members and physicians in the healthcare delivery process.

MEDai's suite of predictive analytic solutions is designed to meet the needs of multiple constituents. This is evidenced by the wide spectrum of clients presenting on MEDai's behalf. Novant Health will share how MEDai's predictive solutions can be applied in the outpatient care environment to allow physicians to access health plan data in real-time for support in evaluating and managing high-risk patients within their practices and in acute care settings. Another client, Sentara Healthcare, will share how they have successfully identified their employer clients' pain points and provided specific reporting and analysis to improve the overall health plan-employer communication process. Finally, during a 3-hour workshop, several other clients will team together to discuss demonstrable ROI, realized through the use of this technology, and innovative concepts to help employers and health plans gain control over rising health plan benefit costs.

"Limited resources require effective allocation and management, and while there is plenty of disparate data available to help with this, many stakeholders do not have the analytical tools that bring that data together and generate accurate, actionable insights," said Swati Abbott, president of MEDai. "MEDai's focus has always and continues to be, creating clinically-focused solutions that provide key information in a timely manner such that everyone involved in the healthcare delivery process can be positively impacted."

About MEDai

MEDai, Inc. is a subsidiary of Elsevier a world-leading publisher of scientific, technical and medical information products and services. For more than a decade, MEDai has been offering award-winning solutions for the improvement of healthcare delivery. Utilizing cutting-edge technology, payors and care management organizations are able to predict patients at risk, identify cost drivers for their high-risk population, forecast future health plan costs, evaluate patient patterns over time and improve outcomes. For more information on MEDai, visit www.medai.com.

    For More Information Contact:
    Lizzy Feliciano, MBA,
    Manager
    Marketing & Communications
    MEDai, Inc.
    (800) 446-3324


'/>"/>
SOURCE MEDai, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Gamma Pharmaceuticals Accepts PO From Leading St. Louis Missouri Distributor. Order Valued up to $850,000 Retail Market Value
2. Stereotaxis Signs Agreement With Leading Leasing Specialist to Offer Alternative Financing to Hospital Customers
3. Three Leading Proxy Advisory Firms are Unanimous in Recommending LCA-Vision Stockholders Support the Current Board of Directors
4. Leading German Healthcare Group Selects Equipment and Software from Varian Medical Systems for Major Replacement Project
5. The Rev. Joseph C. Martin, Leading Authority on Alcoholism and Addiction Treatment, Dies at 84
6. Leading Domestic Violence Expert Comments on New Developments in the Rihanna/Chris Brown Case
7. Dallas-based MedNetwoRx Leading the Way With Healthcare Reform
8. Follow-Up Tests of Leading Personal Care and Household Cleaning Brands Reveal Improvements in Levels of Carcinogenic 1,4-dioxane
9. Leading Proxy Advisory Firm RiskMetrics Recommends Shareholders Support LCA-Vision Board of Directors and Reject All Proposals by Dissident Joffe Group
10. Naturally Safe Zucol(TM) Brings Europes Leading Cold Remedy to United States
11. NHPCO Comments on Misleading Quote in Associated Press Article and Provides Helpful Information
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... December 05, 2016 , ... The new knee compression sleeves ... to buy neoprene knee sleeves for lifting and any sport that requires ... on two main aspects to provide a higher quality knee sleeve performance. Firstly it ...
(Date:12/5/2016)... , ... December 05, 2016 , ... ... today that they have teamed up with The American College of Surgeons (ACS) ... ACS’s Committee on Trauma, the “Bleeding Control Basic” course is a pilot program ...
(Date:12/4/2016)... ... December 03, 2016 , ... ... and many more tools allowing FCPX editors to create professional looking video in ... , Perfect Harmony contains a beautifully designed 3D environment for placing in ...
(Date:12/4/2016)... ... December 04, 2016 , ... "Pro3rd Displace ... animation styles with unique displacement design elements," said Christina Austin - CEO of ... Choose from a variety of design styles that include both left aligned and ...
(Date:12/2/2016)... ... 2016 , ... Halfway through its partnership with First 5 LA, Western University ... than 15,900 children 5 years old and younger and treatment services to more than ... of five years to Western University of Health Sciences, UCLA and USC, beginning March ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... , December 5, 2016 PharmaBoardroom today releases ... . ... This report offers companies, investors, policymakers, and stakeholders crucial insight ... of Europe , home to some of the world,s ... pharmaceutical companies in Novartis and Roche, and with a number one ranking ...
(Date:12/5/2016)... VIENNA and TAIPEI, Taiwan , ... 12 months of treatment ropeginterferon alfa-2b showed non-inferiority to hydroxyurea ... demonstrated a significantly better safety and tolerability profile of ropeginterferon ... data from PROUD-PV and the ongoing long-term follow-up trial CONTINUATION-PV ... PharmaEssentia intends to present this data to the ...
(Date:12/4/2016)... ORLEANS , Dec. 2, 2016  Former Attorney General ... Jr., Esq. , a partner at the law firm of ... commenced an investigation into Lannett Company, Inc. (NYSE: ... Bloomberg published an article titled "U.S. Charges in Generic-Drug ... "antitrust investigation by the Justice Department, begun about two years ...
Breaking Medicine Technology: